维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="Blackstein"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial显示文摘	Ronald P DeMatteo Karla V Ballman Cristina R Antonescu Robert G Maki Peter WT Pisters George D Demetri Martin E Blackstein Charles D Blanke Margaret von Mehren Murray F Brennan Shreyaskumar Patel Martin D McCarter Jonathan A Polikoff Benjamin R Tan Kouros	2009	The Lancet2009，，9669：	2
2	Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment 显示文摘	Blackstein ME Blay JY Corless C	2006	Can J Gastroenterol2006，20，3：	1
3	Stylized rendering techniques for scalable real-time 3D animation 显示文摘	A Lake C arshall M Harris and M Blackstein	2000	In NPAR 2000: First International Symposium on Non-Photorealistic Animation and Rendering2000，1320，：	1
4	Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer 显示文摘	Andrulis IL Bull SB Blackstein ME	1998	J Clin Oncol1998，16，：	1
5	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
6	Gemcitabine as First-line Therapy in patients with metastatic breast cancer:a phase Ⅱ trail显示文摘	Blackstein M Vogel CL Amblinder R	2002	Oncology2002，62，1：	1
7	Perspective on updated treatment guidelines for patients with gastrointestinal stromal tu- mors显示文摘	BLAY JY VON MM BLACKSTEIN ME	2010	Cancer2010，116，22：	1
8	Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors显示文摘	Blay JY von Mehren M Blackstein ME	2010	Cancer2010，116，22：	1
9	Gemcitabine as first line therapy in patients with metastatic breast cancer a phase Ⅱ trial显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
10	Gemeitabine as first line therapy in patients with metastaticbreast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
11	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a Phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，52，1：	1
12	Gemcitabine as first -line therapy in patients with metastatic breast cancer ;a phase Ⅱ trial显示文摘	VOGEL C L AMBINDER R	2002	Oncology2002，62，1：	1
13	Gemcitabine as firsfline thempy in patients with metastatic breast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
14	Gemcitabine as firstline therapy in patients with metastatic breast cancer: aphase II trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
15	Gemcetabine as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trail显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
16	Gemcitabine as first line therapy in patientwith metastatic breast cancer: a phase Ⅱ trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
17	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
18	Updated results from a phase Ⅲ trial of sunitinib in GIST patients (pts) for whom imatinib (IM) therapy has failed due to resistance or intolerance 显示文摘	Casali PG Garrett R Blackstein ME	2006	J Clin Oncol2006，24，18：	1
19	Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors 显示文摘	Poritz LS Blackstein M Berk T	2001	Dis Colon Rectum2001，44，9：	1
20	Gemaitabine as first line therapy in patientswith metastatic breast canter a phase II trial 显示文摘	Blackstein M vogel CL Ambider R	2002	Oneology2002，62，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示